Skip to main content

Table 4 Baseline characteristics of patients with and without hypertension

From: Effect of hypertension on outcomes of adult inpatients with COVID-19 in Wuhan, China: a propensity score–matching analysis

  Before PSM After PSM
Non-hypertension
(n = 142)
Hypertension
(n = 84)
P-value Non-hypertension
(n = 54)
Hypertension
(n = 54)
P-value
Males (%) 62 (42.66%) 51 (60.71%) 0.019 31 (57.71%) 30 (55.56%) 1.000
Age (years) 46.73 (15.20) 65.99 (12.81) < 0.001 60.61 (11.64) 62.93 (13.74) 0.347
Onset time (day) 7.08 (4.00–10.00) 6.92 (4.00–9.75) 0.751 7.63 (4.27) 7.15 (4.25) 0.558
T2DM (%) 11 (7.75%) 34 (40.48%) < 0.001 9 (16.67%) 15 (27.78%) 0.247
CHD (%) 5 (3.52%) 8 (9.52%) 0.078 5 (9.26%) 5 (9.26%) 1.000
COPD (%) 2 (1.41%) 4 (4.76%) 0.198 2 (3.70%) 2 (3.70%) 1.000
WBC (109) 4.89 (3.63–5.90) 5.90 (4.21–7.27) 0.013 5.29 (4.01–7.15) 4.90 (3.66–6.16) 0.285
N/L 2.83 (1.61–5.07) 4.88 (2.95–7.78) < 0.001 5.22 (3.27–7.72) 3.96 (2.17–6.49) 0.05
ALT (U/L) 19.80 (13.60–33.43) 20.75 (14.20–31.80) 0.766 25.65 (16.13–36.60) 24.65 (16.00–36.90) 0.649
AST (U/L) 21.00 (16.88–32.85) 26.85 (20.78–40.68) 0.008 32.15 (19.13–51.13) 25.90 (20.63–39.70) 0.197
ALB (g/L) 39.60 (5.27) 36.44 (4.70) < 0.001 36.63 (4.96) 37.54 (4.44) 0.319
sCr (μmol/L) 64.90 (52.08–74.43) 74.35 (57.63–99.40) 0.001 71.55 (58.93–82.18) 72.05 (57.15–92.40) 0.792
BUN (mmol/L) 3.93 (3.07–5.02) 5.58 (3.66–8.09) < 0.001 4.97 (3.75–6.43) 4.90 (3.62–7.14) 0.578
CRP (mg/dL) 1.16 (0.16–4.55) 6.10 (2.35–8.42) < 0.001 4.74 (2.53–6.74) 4.13 (1.52–7.16) 0.541
D-dimer (μg/mL) 0.52 (0.25–1.54) 1.44 (0.62–6.81) < 0.001 1.21 (0.50–8.59) 1.31 (0.61–6.57) 0.719
  1. Abbreviations: PSM Propensity score–matching analysis; Onset time, time from onset to admission (days); T2DM Type 2 diabetes mellitus; CHD Coronary heart disease; COPD Chronic obstructive pulmonary disease; WBC White blood cell count; N/L Ratio of neutrophils to lymphocytes; ALT Alanine transaminase; AST Aspartate aminotransferase; ALB Serum albumin; sCr Serum creatinine; BUN Blood urea nitrogen; CRP C-reactive protein